JP5735923B2 - ピペラジン塩およびその調製方法 - Google Patents

ピペラジン塩およびその調製方法 Download PDF

Info

Publication number
JP5735923B2
JP5735923B2 JP2011541613A JP2011541613A JP5735923B2 JP 5735923 B2 JP5735923 B2 JP 5735923B2 JP 2011541613 A JP2011541613 A JP 2011541613A JP 2011541613 A JP2011541613 A JP 2011541613A JP 5735923 B2 JP5735923 B2 JP 5735923B2
Authority
JP
Japan
Prior art keywords
trans
tert
butoxycarbonyl
cyclohexyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011541613A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012512239A (ja
JP2012512239A5 (https=
Inventor
チーブラ，ラースツル
アガイン，チョンゴル，エバ
ノグラディ，カタリン
ユハスツ，バーリント
セボク，フェレンク
ガラムボス，ヤーノス
バゴ，イストバーン
Original Assignee
リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ
リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ, リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ filed Critical リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ
Publication of JP2012512239A publication Critical patent/JP2012512239A/ja
Publication of JP2012512239A5 publication Critical patent/JP2012512239A5/ja
Application granted granted Critical
Publication of JP5735923B2 publication Critical patent/JP5735923B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP2011541613A 2008-12-17 2009-12-17 ピペラジン塩およびその調製方法 Active JP5735923B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HUP0800763 2008-12-17
HU0800763A HU230067B1 (hu) 2008-12-17 2008-12-17 Új piperazin só és eljárás előállítására
PCT/HU2009/000108 WO2010070369A1 (en) 2008-12-17 2009-12-17 Piperazine salt and a process for the preparation thereof

Publications (3)

Publication Number Publication Date
JP2012512239A JP2012512239A (ja) 2012-05-31
JP2012512239A5 JP2012512239A5 (https=) 2013-06-13
JP5735923B2 true JP5735923B2 (ja) 2015-06-17

Family

ID=89988672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011541613A Active JP5735923B2 (ja) 2008-12-17 2009-12-17 ピペラジン塩およびその調製方法

Country Status (22)

Country Link
US (1) US8569496B2 (https=)
EP (1) EP2358690B1 (https=)
JP (1) JP5735923B2 (https=)
CN (1) CN102256953B (https=)
AU (1) AU2009329294B2 (https=)
BR (1) BRPI0923007B8 (https=)
CA (1) CA2743924C (https=)
DK (1) DK2358690T3 (https=)
EA (1) EA019024B1 (https=)
ES (1) ES2573957T3 (https=)
GE (1) GEP20125711B (https=)
HR (1) HRP20160726T1 (https=)
HU (2) HU230067B1 (https=)
IL (1) IL212639A0 (https=)
MX (1) MX2011006591A (https=)
NZ (1) NZ592907A (https=)
PL (1) PL2358690T3 (https=)
PT (1) PT2358690E (https=)
SI (1) SI2358690T1 (https=)
TW (1) TWI448455B (https=)
UA (1) UA104163C2 (https=)
WO (1) WO2010070369A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
CA2715760C (en) * 2008-02-21 2017-06-13 Mitsubishi Tanabe Pharma Corporation Solid preparation for oral administration of cariprazine hydrochloride
RS53866B1 (sr) 2008-07-16 2015-08-31 Richter Gedeon Nyrt. Farmaceutske formulacije koje sadrže ligande dopaminskih receptora
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
ITMI20131693A1 (it) 2013-10-14 2015-04-15 Chemo Res S L Derivati della 1,4-cicloesilammina e loro preparazione
CN104496854B (zh) * 2015-01-06 2017-09-22 上海医药工业研究院 3‑环己基‑1,1‑二甲基脲类化合物及其制备方法和应用
HU231173B1 (hu) 2016-07-08 2021-06-28 Richter Gedeon Nyrt. Ipari eljárás cariprazine előállítására
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
CN111269199B (zh) * 2018-12-05 2022-04-08 浙江京新药业股份有限公司 一种卡利拉嗪的制备方法
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
CN111892556A (zh) * 2019-05-06 2020-11-06 北京万全德众医药生物技术有限公司 新的卡利拉嗪制备方法
CN110372557B (zh) * 2019-08-06 2021-05-18 上海勋和医药科技有限公司 环己烷胺类d3/d2受体部分激动剂
CN114539185B (zh) * 2020-11-24 2024-12-24 上海新礼泰药业有限公司 一种卡利拉嗪及其中间体的制备方法
HUP2100108A1 (hu) 2021-03-12 2022-09-28 Richter Gedeon Nyrt Eljárás és berendezés gyógyászatilag alkalmazható piperazin származékok folyamatos áramú, áramlásos konszekutív redukálással történõ elõállítására
CN119874636A (zh) * 2025-01-16 2025-04-25 鲁南制药集团股份有限公司 一种卡利拉嗪的制备方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957921A (en) 1989-12-06 1990-09-18 Warner-Lambert Company Substituted cyclohexanols as central nervous system agents
US5047406A (en) 1989-12-06 1991-09-10 Warner-Lambert Co. Substituted cyclohexanols as central nervous system agents
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
ES2293638T3 (es) 1994-03-25 2008-03-16 Isotechnika, Inc. Mejora de la eficacia de farmacos por deuteracion.
WO1997011070A1 (en) 1995-09-22 1997-03-27 Warner-Lambert Company Substituted cyclohexylamines as central nervous system agents
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
BR9909277A (pt) 1998-03-31 2001-10-16 Acadia Pharm Inc Compostos com atividade em receptores muscarìnicos
SE9802208D0 (sv) 1998-06-22 1998-06-22 Astra Pharma Inc Novel compounds
JP2000191570A (ja) * 1998-12-24 2000-07-11 Sumitomo Chem Co Ltd ヒドロキシフェニルプロパノール類の製造法
US6489341B1 (en) 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
PL364640A1 (en) 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder
US6566550B2 (en) 2001-06-21 2003-05-20 Pfizer Inc Substituted aromatic ethers as inhibitors of glycine transport
HU227543B1 (en) * 2001-09-28 2011-08-29 Richter Gedeon Nyrt N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them
SE0200301D0 (sv) 2002-02-01 2002-02-01 Axon Biochemicals Bv Thio-carbostyril derivative
US6833459B2 (en) * 2002-04-26 2004-12-21 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of thiazole intermediate
US6919342B2 (en) 2003-06-05 2005-07-19 Abbott Gmbh & Co. Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
DE102004047517A1 (de) 2004-09-28 2006-03-30 Merck Patent Gmbh Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid
HUP0500170A3 (en) 2005-02-03 2007-11-28 Richter Gedeon Nyrt Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
GT200600414A (es) 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
JP2008001633A (ja) * 2006-06-22 2008-01-10 Showa Denko Kk テトラヒドロピランを溶媒とする塩化アルミニウム存在下での水素化ホウ素化合物による還元反応
HUP0600809A3 (en) * 2006-10-27 2008-09-29 Richter Gedeon Nyrt New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
HU230748B1 (hu) 2007-05-11 2018-02-28 Richter Gedeon Nyrt Új piperazin só és előállítási eljárása
EP2155200B1 (en) 2007-05-11 2016-12-07 Richter Gedeon Nyrt. Crystalline form of a carbamoyl-cyclohexane derivative
HUP0700353A2 (en) 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700369A2 (en) 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia
HUP0700370A2 (en) 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
AR070513A1 (es) 2007-08-01 2010-04-14 Lundbeck & Co As H Uso de abridores de canales de potasio kcnq para reducir los sintomas o tratar desordenes o afecciones en las cuales se encuentra anulado el sis-tema dopaminergico como por ejemplo esquizofrenia y trastorno depresivo mayor
US7875610B2 (en) 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
CA2715760C (en) 2008-02-21 2017-06-13 Mitsubishi Tanabe Pharma Corporation Solid preparation for oral administration of cariprazine hydrochloride
RS53866B1 (sr) 2008-07-16 2015-08-31 Richter Gedeon Nyrt. Farmaceutske formulacije koje sadrže ligande dopaminskih receptora
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives

Also Published As

Publication number Publication date
EP2358690B1 (en) 2016-03-30
AU2009329294A1 (en) 2010-06-24
CN102256953A (zh) 2011-11-23
UA104163C2 (ru) 2014-01-10
TW201035056A (en) 2010-10-01
EA201170810A1 (ru) 2011-12-30
SI2358690T1 (sl) 2016-07-29
US20110275816A1 (en) 2011-11-10
US8569496B2 (en) 2013-10-29
HUE029667T2 (en) 2017-04-28
HRP20160726T1 (hr) 2016-07-15
BRPI0923007B8 (pt) 2021-10-26
JP2012512239A (ja) 2012-05-31
BRPI0923007B1 (pt) 2021-08-17
CA2743924C (en) 2015-03-31
PL2358690T3 (pl) 2016-10-31
EA019024B1 (ru) 2013-12-30
EP2358690A1 (en) 2011-08-24
DK2358690T3 (en) 2016-07-18
BRPI0923007A2 (pt) 2015-08-11
MX2011006591A (es) 2011-07-12
AU2009329294B2 (en) 2014-04-10
HUP0800763A2 (en) 2010-11-29
NZ592907A (en) 2013-05-31
HU0800763D0 (en) 2009-03-02
CA2743924A1 (en) 2010-06-24
PT2358690E (pt) 2016-06-03
GEP20125711B (en) 2012-12-10
HU230067B1 (hu) 2015-06-29
CN102256953B (zh) 2016-06-01
WO2010070369A8 (en) 2011-04-28
WO2010070369A1 (en) 2010-06-24
ES2573957T3 (es) 2016-06-13
IL212639A0 (en) 2011-07-31
TWI448455B (zh) 2014-08-11

Similar Documents

Publication Publication Date Title
JP5735923B2 (ja) ピペラジン塩およびその調製方法
JP4833080B2 (ja) １−ピペラジン−および１−ホモピペラジン−カルボキシレートの誘導体、その調製方法、およびｆａａｈ酵素の阻害剤としてのその使用
JP4386723B2 (ja) 新規方法
US9260421B2 (en) Pharmaceutical intermediates and process for the preparation thereof
WO2003076374A1 (en) PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
US10227317B2 (en) Process for the preparation of vortioxetine
WO2001023345A1 (en) Process for the preparation of a piperazine derivative
JP2010111684A (ja) キラル２−メチル−４−保護化ピペラジンの立体選択的アルキル化
CN107868033B (zh) 一种苯丙氨酸类化合物的制备方法
EP1971585B1 (en) Process for the preparation of a pharmaceutical intermediate
HK1161587A (en) Piperazine salt and a process for the preparation thereof
HK1161587B (en) Piperazine salt and a process for the preparation thereof
CN1315781C (zh) 制备4－氨基－1－萘酚醚类化合物的方法
WO2007072841A1 (ja) ２－オキシインドール化合物の製法
WO2004020401A1 (en) Synthesis of sulfonamide derivatives
HK1099552B (en) Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics
HU226639B1 (en) {2-[4-(alpha-phenyl-p-chloro-benzyl)-piperazine-1-yl]-ethoxy}-acetic acid-amides and process for producing them

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130423

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140228

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140529

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140627

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140704

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140729

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140805

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20141008

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150204

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150218

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150318

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150417

R150 Certificate of patent or registration of utility model

Ref document number: 5735923

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250